Teva Pharmaceutical Industries Ltd (TEVA)

2,656
-90(-3.28%)
  • वॉल्यूम:
    1,324,962
  • बोली/पुछे:
    2,655/2,656
  • दिन की रेंज:
    2,656 - 2,753
  • प्रकार:इक्विटी
  • बाज़ार:इजराइल
  • आईसआईन:IL0006290147
  • एस/न:629014

TEVA समीक्षा

पिछला बंद
2,746
दिन की रेंज
2,656-2,753
आय
54.88B
खुला
2,724
52 सप्ताह रेंज
2,402-3,401
ईपीएस
-1.95
वॉल्यूम
1,324,962
मार्केट कैप
29.32B
लाभांश (यील्ड)
N/A
(N/A)
औसत वॉल्यूम (3एम)
2,137,712
पी/ई अनुपात
-
बीटा
1.39
1- वर्ष बदलाव
-16.79%
बकाया शेयर
1,110,352,397
अगली कमाई तिथि
26 जुल॰ 2022
Teva पर आपकी भावना क्या है?
या
अभी बाज़ार बंद हैं। वोटिंग बाजार का समय के दौरान खुली है।

Teva Pharmaceutical Industries Ltd कंपनी प्रोफाइल

Teva Pharmaceutical Industries Ltd कंपनी प्रोफाइल

कर्मचारी
35346
बाज़ार
इजराइल

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company’s products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

और पढ़ें

तकनीकी सारांश

प्रकार
5 मिनट
15 मिनट
प्रति घंटा
दैनिक
मासिक
मूविंग एवरेजमजबूत विक्रयमजबूत विक्रयमजबूत विक्रयमजबूत विक्रयमजबूत विक्रय
तकनीकी संकेतकमजबूत विक्रयमजबूत विक्रयमजबूत विक्रयमजबूत विक्रयमजबूत विक्रय
सारांशमजबूत विक्रयमजबूत विक्रयमजबूत विक्रयमजबूत विक्रयमजबूत विक्रय